A significant link between having non-melanoma skin cancer and the chance of developing other types of cancers in the body over one's lifetime, has been shown by a US study published Tuesday.
The researchers, led by University of South Carolina medical doctor Anthony Alberg, said that the risk of coming down with another form of cancer doubles for people who have a history of benign, non-melanoma skin cancer.
Advertisement
They compared the histories over 16 years of 769 people diagnosed with non-melanoma skin cancers, with more than 18,000 people who did not have cancer in the period.
The base figures showed that the skin-cancer sufferers in the study were 3.8 times as likely to be struck with another cancer.
After controlling for other factors such as sex, age, size and habits, the researchers placed the risk at about double.
The link was even more striking for the younger people surveyed, those 25-44, according to the study, published in the Journal of the National Cancer Institute.
Skin cancer is by far the most common type of cancer, newly affecting about one million people each year in the United States alone, according to the American Cancer Society.
Source: AFP
THK/L
After controlling for other factors such as sex, age, size and habits, the researchers placed the risk at about double.
Advertisement
The link was even more striking for the younger people surveyed, those 25-44, according to the study, published in the Journal of the National Cancer Institute.
Skin cancer is by far the most common type of cancer, newly affecting about one million people each year in the United States alone, according to the American Cancer Society.
Source: AFP
THK/L
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
Colorectal cancer can be lowered by up to 7% by increasing dietary consumption of folate rich foods like spinach, broccoli or taking folate supplements.
The effects and mechanisms of microRNA-451a (miR-451a), which hinders the progression of gemcitabine-resistant biliary tract cancers, are under study.
The blood test pinpointed 13 proteins capable of distinguishing between early and late stages of pancreatic cancer.
A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.
Trametinib plus dabrafenib combined therapy demonstrated a clear therapeutic benefit in children with BRAF-mutated low- and high-grade gliomas.